Cook Medical Joins With Trifecta of Indiana Life Science Businesses, Academia and Government to Help Launch Unique Bioscience Research Center
May 30, 2013 10:05 am | by Business Wire | CommentsCook Medical is one of several Indiana life science companies, three research universities and the state government helping launch a unique, industry-led biosciences research center in Indiana. The Indiana Biosciences Research Institute (IBRI), which was announced today at a news conference in Indianapolis, will be a home for Indiana’s best and brightest minds to discover, develop and deliver bioscience innovations.
DiFusion Announces Clinical Solution for Medical Device Infection
May 30, 2013 9:15 am | by Business Wire | CommentsDiFusion announced today the completion of a series of in vitro tests and an in vivo study, carried out in part at Clemson University, to validate the efficacy of its new orthobiologic polymer-CleanFuze™. The in vivo study demonstrated that CleanFuze resists biofilm formation while third party in vitro antimicrobial testing revealed a 99.9999% reduction in S.aureus colonies...
Uscom to Acquire New Zealand-based Pulsecor and New Blood Pressure Products
May 30, 2013 3:18 am | by Business Wire | CommentsUscom (ASX: UCM) Uscom Limited today signed a deed to acquire all assets of Pulsecor Limited. Pulsecor Limited is a New Zealand company which has developed novel non-invasive central blood pressure measurement methods pioneered at the Weill Cornell Medical College in New York.
GE Healthcare Acquires Unisyn Medical Technologies’ Transactional Business
May 29, 2013 2:30 pm | by Business Wire | CommentsGE Healthcare, the healthcare division of General Electric (NYSE: GE), announced today the acquisition of Unisyn Medical Technologies’ Transactional Business, a leading national provider of comprehensive ultrasound probe repair solutions to biomedical and clinical engineers, headquartered in Golden, CO. Financial terms were not disclosed.
Charlotte Based Compression And Vacuum Therapy Technology Helps Train Cyclist In Race Across America
May 29, 2013 11:30 am | by PR Newswire | CommentsAustrian Cyclist Gerald Bauer will be directly benefiting from Charlotte based HYPOXI therapy and equipment to give him a possible racing edge in the Race Across America. Gerald will specifically use the Charlotte HYPOXI Multispectrum S120 device one week prior to the race and each day after the race. Dr. Fedor Fomin of HYPOXI will be providing the therapy.
Research Shows Copper Destroys Norovirus
May 29, 2013 10:03 am | by University of Southampton | CommentsNew research from the University of Southampton shows that copper and copper alloys will rapidly destroy norovirus - the highly-infectious sickness bug. The virus can be contracted from contaminated food or water, person-to-person contact, and contact with contaminated surfaces, meaning surfaces made from copper could effectively shut down one avenue of infection.
The Analysis of Medical Images Is Improved to Facilitate the Study of Psychotic Disorders
May 29, 2013 10:00 am | by UPNA/NUP-Public University of Navarre | CommentsA team of researchers from the UPNA/NUP-Public University of Navarre has developed new super resolution and segmentation methods for magnetic resonance images so that they can be applied to the structural study of psychosis. The aim is to be able to identify the differences that are produced in specific parts of the brain in psychotic patients with respect to their healthy relatives or other people.
Shape-Shifting Nanoparticles Flip from Sphere to Net in Response to Tumor Signal
May 29, 2013 9:44 am | by University of California - San Diego | CommentsScientists at the University of California, San Diego, have designed tiny spherical particles to float easily through the bloodstream after injection, then assemble into a durable scaffold within diseased tissue. An enzyme produced by a specific type of tumor can trigger the transformation of the spheres into netlike structures that accumulate at the site of a cancer, the team reports in the journal Advanced Materials this week.
Digital Chest Tomosynthesis Possible Lung Cancer Screening Tool
May 29, 2013 9:37 am | by International Association for the Study of Lung Cancer | CommentsDigital chest tomosynthesis (DT), a tomographic technique, may offer an alternative to CT screening. A recent study published in the Journal of Thoracic Oncology (JTO), concludes that digital chest tomosynthesis holds promise as a first-line lung cancer screening tool.
New Diagnostic Technology May Lead to Individualized Treatments for Prostate Cancer
May 29, 2013 9:35 am | by Cedars-Sinai Medical Center | CommentsA research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
Global Ultrasound Market to Climb in Next Few Years, Thanks to Emerging Markets
May 29, 2013 9:32 am | by IMS Research | CommentsThe global ultrasound market is forecast to grow by 27 percent over the next five years despite ongoing economic challenges, with emerging healthcare markets key to sustaining future global growth, according to a new report entitled “The World Market for Ultrasound Imaging Equipment – 2013” from IMS Research, now part of IHS Inc. (NYSE: IHS).
Advanced Paper Could be Foundation for Inexpensive Biomedical and Diagnostic Devices
May 29, 2013 9:29 am | by John Toon, Georgia Tech | CommentsPaper is known for its ability to absorb liquids, making it ideal for products such as paper towels. But by modifying the underlying network of cellulose fibers, etching off surface “fluff” and applying a thin chemical coating, researchers have created a new type of paper that repels a wide variety of liquids – including water and oil.
Small Molecule Could Have Big Impact on Cancer
May 29, 2013 9:23 am | by University of Texas at Dallas | CommentsDr. Jung-Mo Ahn, associate professor of chemistry at The University of Texas at Dallas, has designed and synthesized a novel small molecule that might become a large weapon in the fight against prostate cancer. Ahn and his colleagues at UT Southwestern Medical Center describe the design of the molecule as well as laboratory tests that show its effectiveness at blocking the cancer-promoting function of proteins called androgen receptors.
Vycor Issued Strategically Significant U.S. Patent for Its ViewSite(TM) Brain Access System (VBAS)
May 29, 2013 8:30 am | by The Associated Press | CommentsVycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite of FDA cleared products, announced that U.S. patent #12/545719, which relates to its ViewSite Brain Access System ("VBAS"), has been issued. The claims of this patent cover methods for accessing a...
Study of the Use of Control Catheters with the Sensei X Robotic System for the Treatment of Atrial Fibrillation
May 29, 2013 8:00 am | by The Associated Press | CommentsHansen Medical, Inc., a global leader in intravascular robotics, today announced that it has received conditional approval from the U.S. Food and Drug Administration to change the study design of its ARTISAN-AF Trial, a pivotal clinical trial evaluating the use of Hansen Medical's Artisan® family of Control Catheters with its Sensei® X Robotic Catheter System for treatment of Atrial Fibrillation, the most common cardiac arrhythmia.


